Menu
GeneBe

rs2293576

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001128225.3(SLC39A13):​c.573G>A​(p.Ala191=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.32 in 1,613,866 control chromosomes in the GnomAD database, including 87,445 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5897 hom., cov: 33)
Exomes 𝑓: 0.33 ( 81548 hom. )

Consequence

SLC39A13
NM_001128225.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.557
Variant links:
Genes affected
SLC39A13 (HGNC:20859): (solute carrier family 39 member 13) This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. Alternate transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 11-47413435-G-A is Benign according to our data. Variant chr11-47413435-G-A is described in ClinVar as [Benign]. Clinvar id is 384707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-47413435-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.557 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC39A13NM_001128225.3 linkuse as main transcriptc.573G>A p.Ala191= synonymous_variant 5/10 ENST00000362021.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC39A13ENST00000362021.9 linkuse as main transcriptc.573G>A p.Ala191= synonymous_variant 5/101 NM_001128225.3 P4Q96H72-1

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37789
AN:
152046
Hom.:
5899
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.298
Gnomad AMR
AF:
0.230
Gnomad ASJ
AF:
0.347
Gnomad EAS
AF:
0.367
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.334
Gnomad OTH
AF:
0.291
GnomAD3 exomes
AF:
0.310
AC:
77694
AN:
250940
Hom.:
13532
AF XY:
0.325
AC XY:
44106
AN XY:
135754
show subpopulations
Gnomad AFR exome
AF:
0.0597
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.345
Gnomad EAS exome
AF:
0.373
Gnomad SAS exome
AF:
0.460
Gnomad FIN exome
AF:
0.266
Gnomad NFE exome
AF:
0.335
Gnomad OTH exome
AF:
0.322
GnomAD4 exome
AF:
0.327
AC:
478352
AN:
1461700
Hom.:
81548
Cov.:
57
AF XY:
0.332
AC XY:
241608
AN XY:
727170
show subpopulations
Gnomad4 AFR exome
AF:
0.0529
Gnomad4 AMR exome
AF:
0.197
Gnomad4 ASJ exome
AF:
0.350
Gnomad4 EAS exome
AF:
0.308
Gnomad4 SAS exome
AF:
0.451
Gnomad4 FIN exome
AF:
0.270
Gnomad4 NFE exome
AF:
0.334
Gnomad4 OTH exome
AF:
0.325
GnomAD4 genome
AF:
0.248
AC:
37780
AN:
152166
Hom.:
5897
Cov.:
33
AF XY:
0.248
AC XY:
18424
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.0617
Gnomad4 AMR
AF:
0.231
Gnomad4 ASJ
AF:
0.347
Gnomad4 EAS
AF:
0.366
Gnomad4 SAS
AF:
0.452
Gnomad4 FIN
AF:
0.262
Gnomad4 NFE
AF:
0.334
Gnomad4 OTH
AF:
0.288
Alfa
AF:
0.317
Hom.:
13253
Bravo
AF:
0.234
Asia WGS
AF:
0.393
AC:
1367
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 25, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingGeneDxSep 30, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Ehlers-Danlos syndrome, spondylocheirodysplastic type Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.4
DANN
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2293576; hg19: chr11-47434986; COSMIC: COSV61521013; COSMIC: COSV61521013; API